Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antifibrinolytics (lysine Analogues) for the Prevention of Bleeding in People With Haematological Disorders: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders:_Cochrane_systematic_review.
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders:_Cochrane_systematic_review. Accessed January 24, 2026.
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders:_Cochrane_systematic_review
Antifibrinolytics (lysine Analogues) for the Prevention of Bleeding in People With Haematological Disorders: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
ID - 438444
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

